TERRACCIANO, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 2.193
EU - Europa 1.226
AS - Asia 410
AF - Africa 77
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.911
Nazione #
US - Stati Uniti d'America 2.158
IT - Italia 627
CN - Cina 220
NL - Olanda 185
VN - Vietnam 148
CI - Costa d'Avorio 77
IE - Irlanda 71
UA - Ucraina 70
DE - Germania 67
FI - Finlandia 62
GB - Regno Unito 56
SE - Svezia 45
CA - Canada 34
IN - India 21
FR - Francia 12
DK - Danimarca 8
SG - Singapore 7
HK - Hong Kong 6
BE - Belgio 5
ES - Italia 4
CH - Svizzera 3
IR - Iran 3
LT - Lituania 3
AR - Argentina 2
NP - Nepal 2
PK - Pakistan 2
SI - Slovenia 2
AT - Austria 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CL - Cile 1
DO - Repubblica Dominicana 1
EU - Europa 1
HR - Croazia 1
MT - Malta 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 3.911
Città #
Chandler 490
Naples 220
Ashburn 196
Amsterdam 181
Dong Ket 148
Millbury 97
Napoli 91
Beijing 76
Boston 76
Jacksonville 74
Des Moines 60
Princeton 60
Lawrence 58
Nanjing 50
Wilmington 48
Ottawa 31
Woodbridge 22
Dearborn 21
Boardman 20
Washington 19
Nanchang 16
Hebei 15
Fairfield 14
Houston 13
Falls Church 12
Milan 12
Shenyang 12
Kronberg 11
Norwalk 11
Seattle 11
Caserta 10
Oristano 10
Redwood City 10
Rome 10
Changsha 9
Dublin 9
Jiaxing 9
Pune 9
Tianjin 9
Augusta 6
Berlin 6
Formia 6
Hong Kong 6
Los Angeles 6
Salerno 6
Cologno Monzese 5
Lappeenranta 5
London 5
Sciacca 5
Cambridge 4
Cascina 4
Florence 4
Helsinki 4
Wuhan 4
Gesualdo 3
Guangzhou 3
Indiana 3
Lanzhou 3
Marcianise 3
Marigliano 3
Marijampolė 3
Menlo Park 3
New York 3
Orange 3
Paderno Dugnano 3
Parma 3
Salento 3
Serra San Bruno 3
Stradella 3
Turin 3
Acerra 2
Ardabil 2
Aversa 2
Bern 2
Cimitile 2
Contursi 2
Council Bluffs 2
Courcelles 2
Dalmine 2
Edinburgh 2
Ercolano 2
Forlì 2
Formello 2
Frankfurt am Main 2
Giugliano in Campania 2
Groningen 2
Ischia 2
Karachi 2
Kathmandu 2
Kochi 2
Kolkata 2
Latina 2
Limatola 2
Locate di Triulzi 2
Mendoza 2
Monmouth Junction 2
Nocera Inferiore 2
Paris 2
Piana 2
Ragusa 2
Totale 2.434
Nome #
The Biological Role of Vitamins in Athletes’ Muscle, Heart and Microbiota 72
A MOUSE MODEL DEMONSTRATES A MULTIGENIC ORIGIN OF CONGENITAL HYPOTHYROIDISM 69
System for the automated sanitization of containers for biological samples and its process of use 63
Laboratory medicine: health evaluation in elite athletes 63
Comparison between a new thyroglobulin assay with the well-established Beckman Access immunoassay: A preliminary report 54
Acute Effects of Triiodothyronine on Endothelial Function in Human Subjects. 51
Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas. 51
New approaches in the diagnostic procedure of malignant pleural effusions 51
Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials 51
Quercetin and its derivative Q2 modulate chromatin dynamics in adipogenesis and Q2 prevents obesity and metabolic disorders in rats 51
HNP-1 and HBD-1 as biomarkers for the immune systems of elite basketball athletes 51
Analysis of glycoproteins in human colon cancers, normal tissues and in human colon carcinoma cells reactive with monoclonal antibody NCL-19-9 49
Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer 49
Prostate health index vs percent free prostate-specific antigen for prostate cancer detection in men with "gray" prostate-specific antigen levels at first biopsy: Systematic review and meta-analysis 49
Adenoviral gene transfer of PLD1-D4 enhances insulin sensitivity in mice by disrupting phospholipase D1 interaction with PED/PEA-15. 48
Falsely elevated thyroglobulin and calcitonin due to rheumatoid factor in non-relapsing thyroid carcinoma: A case report 48
Oleic acid promotes prostate cancer malignant phenotype via the G protein-coupled receptor FFA1/GPR40 47
Epigenetic signature: A new player as predictor of clinically significant prostate cancer (PCa) in patients on active surveillance (AS) 46
Athlete's Passport: Prevention of Infections, Inflammations, Injuries and Cardiovascular Diseases 45
A New Horizon of Liquid Biopsy in Thymic Epithelial Tumors: The Potential Utility of Circulating Cell-Free DNA 44
alpha1 (I) collagen gene expression in quail epiphyseal chondrocytes 43
INSULIN RESISTANCE (IR) AND PROSTATE CANCER (PCa): THE EFFECT OF NEOADJUVANT ANDROGEN DEPRIVATION THERAPY ON IR IN PATIENTS WITH A DIAGNOSIS OF PCa 42
Effects of the ErbB1/ErbB2 kinase inhibitor GW2974 on androgen-independent prostate cancer PC-3 cell line growth and NSE, chromogranin A and osteopontin content. 42
Matrix metalloproteinase-2 and -9 in the urine of prostate cancer patients. 42
Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management-Current Trends and Future Perspectives 42
alpha1(I) collagen gene expression in quail epiphyseal chondrocytes. 40
Long non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis 40
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis 40
Colorimetric Test for Fast Detection of SARS-CoV-2 in Nasal and Throat Swabs 40
Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy 39
Improving the prediction of pathologic outcomes in patients undergoing radical prostatectomy: the value of prostate cancer antigen 3 (PCA3), prostate health index (phi) and sarcosine 39
Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance 39
Sistema per la sanificazione automatizzata di contenitori per campioni biologici e suo procedimento di utilizzo 38
Biomarkers in localized prostate cancer 38
Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I Trial 38
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor 38
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study 38
Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomy 37
Urinary gelatinase activities (matrix metalloproteinases 2 and 9) in human bladder tumors 36
Rhes is involved in strial function 36
Preoperative insulin-like growth factor-binding protein-3 (IGFBP-3) blood level predicts gleason sum upgrading 36
Modified glasgow prognostic score is associated with risk of recurrence in bladder cancer patients after radical Cystectomy: A multicenter experience 36
Neutrophil, platelets, and eosinophil to lymphocyte ratios predict gleason score upgrading in low-risk prostate cancer patients 36
Childhood obesity: an overview of laboratory medicine, exercise and microbiome 36
Plasmatic Sil 6r/il-6 Ratio As A Potential Predictor of High Gleason Sum At Radical Prostatectomy 35
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 35
Soluble interleukin-6 receptor to interleukin-6 (sIL-6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy 34
Predicting pathological features at radical prostatectomy in patients with prostate cancer eligible for active surveillance by multiparametric magnetic resonance imaging 34
Cyclic AMP-dependent secretion of Ca 19-9 by LS 174T human colon carcinoma cells 33
Beyond PSA: The Role of Prostate Health Index (phi) 33
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer 33
Peri-Prostatic Adipocyte-Released TGFβ Enhances Prostate Cancer Cell Motility by Upregulation of Connective Tissue Growth Factor 33
Diagnostic value of carbohydrate antigens in supernatantsand sediments of pleural effusions 32
Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitro 32
Seroprevalence of SARS-CoV-2 Assessed by Four Chemiluminescence Immunoassays and One Immunocromatography Test for SARS-Cov-2 32
Role of cytokeratins, nuclear matrix proteins, Lewis antigen and epidermal growth factor receptor in human bladder tumors. 31
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance 31
New Cross-Talk Layer between Ultraconserved Non-Coding RNAs, MicroRNAs and Polycomb Protein YY1 in Bladder Cancer 31
The role of a new class of long noncoding RNAs transcribed from ultraconserved regions in cancer 31
Periprostatic adipose tissue promotes prostate cancer resistance to docetaxel by paracrine IGF‐1 upregulation of TUBB2B beta‐tubulin isoform 31
Expression of Lewis carbohydrate antigen in human tumors. 30
Iodine status assessment in Campania (Italy) as determined by urinary iodine excretion. 30
Salvage radical prostatectomy after external beam radiation therapy: A systematic review of current approaches 30
The evolving role of monoclonal antibodies in the treatment of patients with advanced renal cell carcinoma: a systematic review 30
Enhancement of vascular endothelial function by recombinant human thyrotropin 30
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 30
Circular RNAs: An emerging type of non-coding RNA and their potential implications in bladder cancer 30
Optimized Identification of High-Grade Prostate Cancer by Combining Different PSA Molecular Forms and PSA Density in a Deep Learning Model 30
The emerging role of obesity, diet and lipid metabolism in prostate cancer 29
Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade/grade 3 bladder cancer 29
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis 29
Impact of Age on Outcomes of Patients With Pure Carcinoma In Situ of the Bladder: Multi-Institutional Cohort Analysis 29
Alteraziioni genetiche ed epigenetiche di Prep1 nel diabete mellito. 28
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer 28
Integration of lipidomics and transcriptomics reveals reprogramming of the lipid metabolism and composition in clear cell renal cell carcinoma 28
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 28
SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study 28
Perspective: Cancer Patient Management Challenges During the COVID-19 Pandemic 27
Matrix metalloroteinase-2 and matrix metalloproteinase-9 type IV collagenases in serum of patients with pleural effusions 26
Gelatinolytic activities (matrix metalloproteinase-2 and -9) and soluble extracellular domain of Her-2/neu in pleural effusions. 26
Conditional inactivation of the E-cadherin gene in thyroid follicular cells affects gland development but does not impair junction formation. 26
COVID-19 vaccine mRNABNT162b2 elicits human antibody response in milk of breastfeeding women 26
Evaluation of a fully closed real time PCR platform for the detection of SARS-CoV-2 in nasopharyngeal swabs: a pilot study 25
Prostate health index and multiparametric mri: Partners in crime fighting overdiagnosis and overtreatment in prostate cancer 25
Liquid Biopsy in Prostate Cancer Management{\textemdash}Current Challenges and Future Perspectives 24
Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) Significantly Improve Prostate Cancer Detection at Initial Biopsy in a Total PSA Range of 2-10 ng/ml 24
Comparison of anti–hepatitis D virus (HDV) ETI-AB-DELTAK-2 assay and the novel LIAISON® XL MUREX anti-HDV assay in the diagnosis of HDV infection 24
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update 24
Mean reticolocyte hemoglobin content index plays a key role to identify children who are carriers of β-thalassemia 24
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy 24
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies 24
A Combinatorial Neural Network Analysis Reveals a Synergistic Behaviour of Multiparametric Magnetic Resonance and Prostate Health Index in the Identification of Clinically Significant Prostate Cancer 24
New strategy for the identification of prostate cancer: The combination of Proclarix and the prostate health index 23
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 23
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer 23
Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies 23
Subcellular Localization of uc.8+ as a Prognostic Biomarker in Bladder Cancer Tissue 22
Prostate cancer radiogenomics—from imaging to molecular characterization 22
Cytokine signature and COVID-19 prediction models in the two waves of pandemics 22
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings 22
Totale 3.553
Categoria #
all - tutte 18.003
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.003


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20198 0 0 0 0 0 0 0 0 0 0 1 7
2019/2020380 116 6 19 12 18 15 31 17 10 42 50 44
2020/2021501 12 14 32 23 36 52 26 10 68 27 35 166
2021/2022856 18 12 11 3 21 12 24 31 86 83 262 293
2022/20231.267 140 102 48 59 148 138 16 126 183 197 83 27
2023/2024850 38 134 206 110 68 95 16 132 27 23 1 0
Totale 4.156